Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR139 | Q6DWJ6 | 2/20 | 0.60 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.56 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.56 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.56 |
| ▸ | CTSL | P07711 | 3/20 | 0.48 |
| ▸ | CTSS | P25774 | 1/20 | 0.48 |
| ▸ | CTSK | P43235 | 1/20 | 0.48 |
| ▸ | KLKB1 | P03952 | 2/20 | 0.46 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.46 |
| ▸ | HPGDS | O60760 | 1/20 | 0.46 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.45 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20964465 | 0.90 | PRSS1 (0.54) | GPR139PRSS1PRSS2PRSS3CTSL | |
| SCHEMBL24179836 | 0.88 | GPR139 (0.61) | GPR139PRSS1PRSS2PRSS3CTSL | |
| SCHEMBL20964423 | 0.88 | PRSS1 (0.61) | PRSS1PRSS2PRSS3CTSLCTSS | |
| SCHEMBL20964413 | 0.85 | PRSS1 (0.57) | PRSS1PRSS2PRSS3CTSLCTSS | |
| SCHEMBL20964463 | 0.83 | GHSR (0.46) | PRSS1PRSS2PRSS3CTSL | |
| SCHEMBL24179837 | 0.83 | PSMB5 (0.52) | PRSS1PRSS2PRSS3CTSL | |
| SCHEMBL24179827 | 0.82 | PRSS1 (0.58) | PRSS1PRSS2PRSS3CTSLCTSS | |
| SCHEMBL20964453 | 0.82 | PTPN1 (0.57) | PRSS1PRSS2PRSS3CTSL | |
| SCHEMBL24179824 | 0.82 | PRSS1 (0.54) | PRSS1PRSS2PRSS3CTSLHPGDS | |
| SCHEMBL20964434 | 0.82 | PRSS1 (0.54) | PRSS1PRSS2PRSS3CTSLHPGDS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190127419-A1 | NEUROPEPTIDE S RECEPTOR (NPSR) AGONISTS | RESEARCH TRIANGLE INSTITUTE | 2019-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190127419-A1 | NEUROPEPTIDE S RECEPTOR (NPSR) AGONISTS | NPSR1, GRPR, NPBWR1 | GPR139 43/4885PRSS1 195/4885PRSS2 395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.